« Forum down -- back up now | Main | Meet FAH team member Del Lucent »

September 20, 2007



I recall that the drug design wasn't a main objective of the FAH. Has it changed?


To measure affinity, does that mean you simulate both the proposed drug and the suggested target(s) and count the number of and speed of the bindings that take place?

How many atoms per simulation are you talking about?


H-m, does Pande group have excess of computational resources for participating in outside projects?!

The comments to this entry are closed.